MarketInOut Stock Screener Log In | Sign Up

Sandoz Group AG

SIX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Sandoz Group AG stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSIX
Market Capitalization35,524 mln
Float415 mln
Earnings Date10/30/2026

EPS

1.17
Stretched

P / E

70.41
Richly valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.61
Likely reliable

1-Year Forecast

78.94
Fairly priced

Relative Strength

95 / 100
Top performer

Business Description

Sandoz Group AG is a Swiss pharmaceutical company founded in 1886 and based in Basel, with operations spanning the globe. The company specializes in generic medicines and biosimilars, offering affordable treatment options across a broad range of health conditions, from heart disease and cancer to rare disorders and diabetes. Sandoz also supplies the raw pharmaceutical ingredients and finished drug products that other manufacturers and healthcare providers rely on.

Key Fundamentals

EPS1.17
P/E70.41
ROE7.12
RPS22.05
ROIC7.29
ROA2.91
Interest Cover8.14
EBITDA, mln1,310
EV / EBITDA27.15
EV / EBIT42.19
Revenue, mln9,215
EV / Revenue3.86

Quote Details

Last 82.38
Change -1 (-1.2%)
Open 84.00
Volume 1,074,428
Turnover 88,511,376
Average Volume 1,147,801

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio2.53
Current Ratio1.05
Price / Book4.22
Price / Cash Flow22.35
Price / Free Cash Flow28.71
Debt / Equity0.69
Price / Sales3.37
PEG Ratio1.25

Financial Strength

Altman Z-Score3.24
Piotroski F-Score 5 / 9
Beneish M-Score-2.61
1-Year Target Price78.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.13% 84 / 100   
1 Month 20.4% 99 / 100   
2 Months 26.66% 96 / 100   
6 Months 24.89% 92 / 100   
1 Year 69.82% 97 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog